Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
McGuigan
C
C
Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF1 3XF, U.K.
Barucki
H
H
Carangio
A
A
Blewett
S
S
Srinivasan
S
S
Andrei
G
G
Snoeck
R
R
De Clercq
E
E
Balzarini
J
J
D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D001087:Arabinonucleosides / Q000138:chemical synthesis* / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000138:chemical synthesis / Q000494:pharmacology; D002478:Cells, Cultured; D005347:Fibroblasts / Q000821:virology; D014645:Herpesvirus 3, Human / Q000187:drug effects*; D006801:Humans; D011741:Pyrimidine Nucleosides / Q000138:chemical synthesis* / Q000494:pharmacology*
D000998:Antiviral Agents; D001087:Arabinonucleosides; D019086:Bridged Bicyclo Compounds, Heterocyclic; D011741:Pyrimidine Nucleosides